Study of the Effect of Vagus Nerve Stimulation on Human Brown Adipose Tissue Activity
NCT ID: NCT01491282
Last Updated: 2011-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
5 participants
OBSERVATIONAL
2011-01-31
2012-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No treatment
Enabling and disabling VNS
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enabling and disabling VNS
No intervention
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Daily epileptic insults.
* Subjects that need 'Rapid Cycling' VNS to control their frequency of epileptic insults.
* Psychological unstable subjects (as judged by the treating neurologist).
* subjects with mental retardation (as judged by the treating neurologist).
* subjects with severe behaviour disorders (as judged by the treating neurologist).
* Pregnant subjects.
* Subjects that previously underwent high dose radiation for diagnostic or therapeutic purposes (radiotherapy, high frequency CT-scans).
* The use of the following medication is an exclusion criterium;
* ß-blockers,
* Ketogenic diet
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
dr. Sef Janssen
Dr. W.D. van Marken Lichtenbelt
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wouter D. van Marken Lichtenbelt, PhD.
Role: PRINCIPAL_INVESTIGATOR
Department of Human Biology, Maastricht University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University
Maastricht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Guy H.E.J. Vijgen, M.D.
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Vijgen GH, Bouvy ND, Leenen L, Rijkers K, Cornips E, Majoie M, Brans B, van Marken Lichtenbelt WD. Vagus nerve stimulation increases energy expenditure: relation to brown adipose tissue activity. PLoS One. 2013 Oct 23;8(10):e77221. doi: 10.1371/journal.pone.0077221. eCollection 2013.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MEC 10-3-071
Identifier Type: -
Identifier Source: org_study_id